HPV Vaccine Appears Safe in Early Pregnancy
|
By HospiMedica International staff writers Posted on 14 Apr 2017 |
|
A new study suggests that vaccination against human papillomavirus (HPV) during pregnancy does not increase the risk of maternal or fetal complications.
Researchers at the Danish Statens Serum Institut conducted a retrospective study of all women in Denmark who had a pregnancy that ended between October 1, 2006, and November 30, 2013. Using nationwide registers, the researchers linked data on quadrivalent HPV vaccination, adverse pregnancy outcomes, and potential confounders. Vaccinated women were matched on a 1:4 ratio with women who were not. Study outcomes included a range of gestational and newborn factors.
The results revealed 65 birth defects in vaccine-exposed pregnancies, compared to 220 in unexposed pregnancies; 20 spontaneous abortions with vaccine exposure versus 131 without; 116 preterm births versus 407; 76 cases of low birth weight versus 277; 171 cases of small size for gestational age versus 783; and two stillbirths versus four. Upon analysis, exposure to HPV vaccine was not associated with significantly higher risks for major birth defect, spontaneous abortion, preterm birth, low birth weight, small size for gestational age, or stillbirth. The study was published on March 30, 2017, in the New England Journal of Medicine (NEJM).
“Our results are consistent with other evidence that does not indicate that the vaccination of pregnant women with inactivated virus, bacterial, or toxoid vaccines generally confers a higher risk of adverse pregnancy outcomes than no such vaccination,” concluded lead author Nikolai Scheller, MD, and colleagues. “Our results also confirm and considerably expand on results from previous studies of the quadrivalent HPV vaccine.”
Introduced in 2006, the quadrivalent HPV vaccine covers the four viral strains most closely associated with gynecologic cancer (HPV-6, 11, 16, and 18). HPV types 6 and 11 also cause genital warts. As of 2014, 58 countries include HPV in their routine vaccinations for all girls around the ages of 9-13, and some countries vaccinate boys as well; the vaccines provide protection for at least eight years. Denmark also vaccinates women up to 26 years of age, and as a result some women are inadvertently exposed to HPV vaccination during early pregnancy.
Researchers at the Danish Statens Serum Institut conducted a retrospective study of all women in Denmark who had a pregnancy that ended between October 1, 2006, and November 30, 2013. Using nationwide registers, the researchers linked data on quadrivalent HPV vaccination, adverse pregnancy outcomes, and potential confounders. Vaccinated women were matched on a 1:4 ratio with women who were not. Study outcomes included a range of gestational and newborn factors.
The results revealed 65 birth defects in vaccine-exposed pregnancies, compared to 220 in unexposed pregnancies; 20 spontaneous abortions with vaccine exposure versus 131 without; 116 preterm births versus 407; 76 cases of low birth weight versus 277; 171 cases of small size for gestational age versus 783; and two stillbirths versus four. Upon analysis, exposure to HPV vaccine was not associated with significantly higher risks for major birth defect, spontaneous abortion, preterm birth, low birth weight, small size for gestational age, or stillbirth. The study was published on March 30, 2017, in the New England Journal of Medicine (NEJM).
“Our results are consistent with other evidence that does not indicate that the vaccination of pregnant women with inactivated virus, bacterial, or toxoid vaccines generally confers a higher risk of adverse pregnancy outcomes than no such vaccination,” concluded lead author Nikolai Scheller, MD, and colleagues. “Our results also confirm and considerably expand on results from previous studies of the quadrivalent HPV vaccine.”
Introduced in 2006, the quadrivalent HPV vaccine covers the four viral strains most closely associated with gynecologic cancer (HPV-6, 11, 16, and 18). HPV types 6 and 11 also cause genital warts. As of 2014, 58 countries include HPV in their routine vaccinations for all girls around the ages of 9-13, and some countries vaccinate boys as well; the vaccines provide protection for at least eight years. Denmark also vaccinates women up to 26 years of age, and as a result some women are inadvertently exposed to HPV vaccination during early pregnancy.
Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Shoulder System
Identity Shoulder System
New
Radial Artery Compression Device
TR Band
Latest Patient Care News
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
Channels
Critical Care
view channel
Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
Hypertension affects nearly half of all adults in the U.S. and remains the leading cause of cardiovascular disease. Regular and accurate blood pressure monitoring is essential for managing this condition,... Read more
New Understanding of Barrett’s Esophagus Formation to Enable Earlier Intervention and Diagnosis
Barrett’s esophagus is a condition in which the lining of the esophagus—normally composed of squamous epithelial cells—undergoes a transformation into cells resembling those found in the stomach or intestine.... Read more
Surgical Techniques
view channel
Neuroform Atlas Stent-Assisted Coiling Found Effective Even in Smaller Arteries
Aneurysms, especially when located in the brain, can be life-threatening if not treated effectively. Intracranial aneurysms, caused by the dilation of blood vessels due to weaknesses in the vessel wall,... Read more
New Surgical Technique Safely Removes Giant Nerve Tumors
Giant plexiform neurofibromas (PNF) are benign tumors commonly associated with neurofibromatosis Type 1 (NF1), a genetic disorder affecting approximately 1 in 3,000 live births. These tumors, which occur... Read more
Health IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Business
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
